Role of APCC in managing Haemophilia with inhibitors
Wednesday, July 9th 2025 - 1:30 PM (IST)
5 days to Go
80 doctors attending
Wednesday, July 9th 2025 - 1:30 PM (IST)
ABOUT THIS SESSION
Managing haemophilia with inhibitors remains one of the most complex challenges in bleeding disorder care. Standard factor replacement therapies often become ineffective, leading to increased bleeding risk and reduced quality of life. This session explores the role of Activated Prothrombin Complex Concentrates (APCC) as a critical bypassing agent in overcoming these treatment hurdles. Join us to understand the indications, dosing strategies, and clinical considerations involved in APCC use, and how it can be integrated effectively into the management of patients with haemophilia and inhibitors.
KEY DETAILS
Registration
Free
Duration
60 min
Replay
Yes
Certificate
No
Language
English
EXPLORE OTHER SESSIONS
Disclaimer
About: Medflix is owned and operated by Medflix Learning Pvt. Ltd. and is being used by Takeda under an appropriate agreement for providing you access to webinars.
1. You should not allow the contents shared in the webinar or online platform to substitute for your own independent medical judgment, which you should exercise in evaluating the information on this platform and should not be used for diagnosing or treating a health problem or disease.
2. Nothing in this webinar or online platform should be construed as the giving of advice or the making of a recommendation regarding any decision or action related to your patient’s health, nor it is intended for use in the diagnosis of disease or other conditions, or the cure, mitigation, treatment, or prevention of disease.
3. This online platform contains copyright protected information, content; the use of which is limited by law and this material cannot be reproduced, replicated, used or modified by any person for their own use or further distribution.
4. Takeda does not warrant that any content or information contained on this online platform is accurate, correct, complete or up-to-date, and hereby disclaims any and all liability to any person for any actual or threatened loss or damage caused by errors or omissions, whether such errors or omissions result from negligence, accident or otherwise. Takeda assumes no liability for the interpretation and/or use of the content and/or information contained on this online platform, nor does it offer any warranty of any kind, either expressed or implied in relation to such content or information.
5. Takeda takes no responsibility for and will not be liable for the technical reasons for unavailability of the webinar or the online-platform due to technical issues beyond Takeda’s control.
Copyright © 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Contact us: Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Pvt. Ltd.)
6th Floor, Tower-C, Building No.8, DLF Cyber City, DLF Phase-II,
Gurgaon-122002, Haryana, India
Tel +91-124-4559100 www.takeda.com
Takeda - Better Health, Brighter Future
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Note : This page may be accessed by healthcare/allied healthcare professionals only.